ExCellThera inc.
ExCellThera inc.
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma | Hemic and Lymphatic Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, epithelial neoplasm, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myeloid leukemia, neoplasm, neuroblastoma, neuroepithelial neoplasm, paroxysmal nonkinesigenic dyskinesia, primitive neuroectodermal tumor | Not yet recruiting | Phase 1 | 2026-04-08 | NCT07518654 | |
| UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia | Cord Blood Transplant; High Risk Hematologic Malignancy | Active, not recruiting | Phase 2 | 2025-10-27 | NCT03913026 |